A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study - Yazici, Y; McAlindon, T E; Fleischmann, R (Osteoarthritis Cartilage, 2017)